ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: FR-PO675

APOL1-B3 Isoform Is Involved in the Processing of the IL-1β Production

Session Information

Category: Glomerular

  • 1001 Glomerular: Basic/Experimental Immunology and Inflammation

Authors

  • Wakashin, Hidefumi, Dokkyo Medical University, Shimotsuga, Japan
  • Kopp, Jeffrey B., NIDDK, NIH, Bethesda, Maryland, United States
Background

APOL1 genetic variants G1 and G2 increase risk for glomerular disease. Previously, we identified an intracellular splice isoform, APOL1-B3, that is expressed in glomerular cells and tubular cells in vivo (ms submitted). In transgenic mice, APOL1-B3-G2 expression enhanced podocyte injury, increased pro-IL-1β mRNA from isolated glomeruli, and increased renal IL-1β protein production. APOL1-B3 interacted with NLRP12, a negative regulator of Toll-like receptor signaling, potentially explaining elevation of pro-IL-1β mRNA in glomeruli. Here we examined the role of APOL1-B3 in inflammasome activation and production of mature IL-1β.

Methods

We generated stable THP-1 monocytic cell lines expressing APOL1 under the control of the chicken actin promoter, CAG-APOL1-B3-FLAG-G0 (common variant) or -G2 (renal risk variant); G1 variant cells were not viable. THP-1 cells were treated with phorbol myristate acetate to induce differentiation into macrophages, which were stimulated with lipopolysaccharide (LPS) and nigericin to activate inflammasomes. We generated CAG-APOL1-B3 transgenic mice, using linear DNA encoding CAG promoter-APOL1-B3 (G0 or G2), with FLAG-SV40 polyA signal sequence. Mice were studied at 6-8 w of age. Random urine was obtained prior to and 3 days after uninephrectomy.

Results

In THP-1 derived macrophages, over expression of APOL1-B3-G0 and –G2 significantly enhanced both LPS-stimulated IL-1β production (mean±SD: control =193±3.8, G0=585±33, G2=669±79) (P<0.05) and release of caspase-1 into supernatant (control =3393±520, G0=9828±1541, G2= 6783±608) (P<0.05). Following uninephrectomy, increased urinary caspase-1 was seen in both APOL-B3 mice (G0, G2) and wild type mice, with no difference among groups. The ratio of IL-1β to pro-IL-1β in the kidney, assessed by Western blot, increased following uninephrectomy, and was numerically greater in APOL1-B3-G2 mice. These findings suggest enhanced processing of pro-IL-1β by the APOL1 risk variant . By Western blot, both APOL1-B3-G0- and -G2 interacted with NLRP3.

Conclusion

These findings suggest that under the conditions studied, the APOL1-B3 isoform affects processing of IL-1b and add a further dimension to the role of APOL1-B3 in modulating NLRP3 pathway signaling.